Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revvity, Inc. Common Stock (NY:RVTY)

166.51 +14.91 (+9.84%)
Delayed Quote Updated: 3:36 PM EST, Nov 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Revvity, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Revvity Analysts Increase Their Forecasts After Q3 Earnings ↗
 
Via Benzinga
News headline image
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
News headline image
RVTY Q3 Deep Dive: AI Initiatives and Segment Divergence Shape Outlook
Life sciences company Revvity (NYSE:RVTY) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 2.2% year on year to $698.9 million. The company’s outlook for the full year was close to... 
Via StockStory
Topics Artificial Intelligence
News headline image
These S&P500 stocks are moving in today's session ↗
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Monday. 
Via Chartmill
News headline image
Revvity Earnings Preview ↗
 
Via Benzinga
News headline image
What Analysts Are Saying About Revvity Stock ↗
 
Via Benzinga
News headline image
Revvity (RVTY) Stock Trades Down, Here Is Why
Shares of life sciences company Revvity (NYSE:RVTY) fell 2.4% in the afternoon session after it reported third-quarter financial results that showed a drop in profits and margins, even as revenue... 
Via StockStory
Topics Economy Government World Trade
News headline image
Tech Stocks Rally, Gold Tumbles On US-China Trade Progress: What's Moving Markets Monday? ↗
Wall Street extended its record-setting streak on Monday, with major large-cap indices logging a third consecutive session of strong gains after a breakthrough in trade negotiations between Washington... 
Via Benzinga
News headline image
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Monday and stay ahead of the market trends. 
Via Chartmill
News headline image
Which S&P500 stocks are moving before the opening bell on Monday? ↗
Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
Revvity Lifts Profit Outlook, Launches $1 Billion Buyback Plan ↗
Revvity Inc. (NYSE: RVTY) announced mixed Q3 results, beating EPS but missing revenue estimates, leading to a decline in stock price. 
Via Benzinga
News headline image
Revvity Inc (NYSE:RVTY) Q3 2025 Earnings: EPS Beats Estimates, Revenue Falls Short ↗
Revvity's Q3 2025 earnings beat EPS estimates but revenue was slightly below forecasts. The company announced a new $1 billion share buyback program. 
Via Chartmill
Topics Earnings
News headline image
Revvity (NYSE:RVTY) Posts Q3 Sales In Line With Estimates
Life sciences company Revvity (NYSE:RVTY) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 2.2% year on year to $698.9 million. The company’s outlook for the full year was close to... 
Via StockStory
News headline image
Revvity Announces Financial Results for the Third Quarter of 2025
From Revvity
Via Business Wire
News headline image
Earnings Scheduled For October 27, 2025 ↗
 
Via Benzinga
News headline image
Revvity (RVTY) Q3 Earnings Report Preview: What To Look For
Life sciences company Revvity (NYSE:RVTY) will be announcing earnings results this Monday before the bell. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
News headline image
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
News headline image
What's Driving the Market Sentiment Around Revvity Inc? ↗
 
Via Benzinga
News headline image
Research Tools & Consumables Stocks Q2 Teardown: Revvity (NYSE:RVTY) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at research tools & consumables stocks,... 
Via StockStory
Topics Economy
News headline image
Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions
Washington D.C. – The Federal Reserve has sent clear signals of a continued dovish pivot, with Chair Jerome Powell indicating the likelihood of two additional quarter-point interest rate cuts before... 
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
News headline image
Revvity Showcases Progress with Purpose in 2025 Impact Report
From Revvity
Via Business Wire
News headline image
Medpace and Revvity Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
News headline image
Revvity to Hold Earnings Call on Monday, October 27, 2025
From Revvity
Via Business Wire
News headline image
1 Profitable Stock to Own for Decades and 2 We Turn Down
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
Topics Economy
News headline image
Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes
From Revvity
Via Business Wire
News headline image
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Agilent (A) Soars as White House-Pfizer Drug-Pricing Agreement Signals New Era for Pharma
Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Pharmaceutical Pricing Shake-Up Casts Long Shadow on Biotech Suppliers, Bruker Navigates Headwinds Amidst Market Volatility
As of September 30, 2025, the financial markets are grappling with the implications of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE), a move... 
Via MarketMinute
Topics Economy Government Supply Chain
News headline image
Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
Via StockStory
Topics Government
News headline image
Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis
From Revvity
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.